Hepatitis C virus (HCV) continues to be the number one cause of cirrhosis and liver cancer and the primary indicator for liver transplantation in the United States, yet it remains vastly underdiagnosed.
More than three million people in the U.S. are infected. Guidelines support widespread screening for HCV, and excellent treatments are now available.
So the question remains: Why is HCV underreported?
When “good” news disguises bad
A recently published Read more…